Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
Outside influences on CHD8 variant phenotypes, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 18 May.
Outside influences on CHD8 variant phenotypes, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 18 May.
By
Jill Adams
19 May 2026 | 2 min read
Reforming neuroscience graduate education for—and with—AI
In disrupting the status quo, artificial intelligence can help us critically reassess and redefine what neuroscience graduate training should look like—and potentially address long-standing training challenges in novel and innovative ways.
Reforming neuroscience graduate education for—and with—AI
In disrupting the status quo, artificial intelligence can help us critically reassess and redefine what neuroscience graduate training should look like—and potentially address long-standing training challenges in novel and innovative ways.
By
Tari Tan
19 May 2026 | 7 min read
What can AI teach us about ‘emotions’?
Exploring why Anthropic’s AI, Claude, displays something like emotion could ultimately help us better understand the function that emotions serve in humans.
What can AI teach us about ‘emotions’?
Exploring why Anthropic’s AI, Claude, displays something like emotion could ultimately help us better understand the function that emotions serve in humans.
By
Nicole Rust
18 May 2026 | 7 min read